Dementia and comorbidities: ensuring parity of care

International Longevity Centre, April 2016

This report, supported by Pfizer, argues that a failure to prevent, diagnose and treat depression, diabetes and urinary tract infections in people with dementia could cost the UK’s health and care system up to nearly £1 billion per year. It highlights a lack of parity in the diagnosis of these conditions in people with dementia and outlines some recommendations including revision of NICE clinical guidelines; greater patient involvement in care plans; and commissioning of a wider range of psychological therapies.

Click here to view the full report.